期刊文献+

靛玉红抗斑马鱼胚胎血管生成活性机制研究 被引量:6

Indirubin inhibits angiogenesis in zebrafish embryos and its mechanism
原文传递
导出
摘要 目的:研究靛玉红抗血管生成作用及相关机制。方法:以tgfli1:eGFP(+/-)斑马鱼为模型,实验分空白对照组、二甲基亚砜组、靛玉红组(15μM、30μM、90μM)、阳性SU5416对照组,在12hpf时加药,于48hpf时在荧光显微镜下观察其体节间血管生成情况,并进行定量分析。运用整体原位杂交的方法和RT-PCR技术检测flk1基因的表达情况。结果:与空白对照组相比,靛玉红各浓度组体节间血管长度有显著性差异(P<0.01),并呈剂量依赖性抑制;与空白对照组相比,靛玉红对斑马鱼胚胎flk1mRNA表达有明显抑制作用,并随浓度的增高而增加。结论:靛玉红(15μM~90μM)具有抑制斑马鱼胚胎体节间血管生成的作用,其机制可能是通过阻断VEGF/VEGFR2信号通路的某个环节来发挥作用。 Objective: To investigate the antiangiogenic activity and related mechanism of indirubin in zebrafish embryos. Methods: The antiangio- genic activity was tested with in vivo transgenic zebrafish embryos, and its mechanism was clarified in zebra_fish by gene expression analysis of the vascular endothelial growth factor receptor2 (VEGFR2) . The expression of VEGFR2 was detected by RT-PCR assay and whole mount in situ hybridization (WISH). Results: The treatment of zebrafish embryos with indirubin manifested potent anti-angiogenic activity against in- tersegmental vessels formation. WISH and semi-quantitative RT-PCR analysis showed that indirubin dose-dependently reduced the mRNA ex- pression of vascular endothelial growth factor (VEGF) receptor2 (VEGFR2). Conclusions: The study suggested that indirubin could inhibit angiogenesis of intersegmental vessels of the zebrafish embryos through inhibition of the phosphorylation of certain protein in the VEGF/VEG- FR2 pathway, which results in down-regulation of VEGFR2 mRNA expression.
出处 《中药药理与临床》 CAS CSCD 北大核心 2012年第4期32-34,共3页 Pharmacology and Clinics of Chinese Materia Medica
基金 广州市白云区科技计划 课题号:2010-KZ-37
关键词 靛玉红 血管生成 血管内皮生长因子受体 斑马鱼 indirubin (靛玉红) angiogenesis vascular endothelial growth factor receptor zebrafish
  • 相关文献

参考文献17

  • 1Folkman J.Tumor angiogenesis:therapeutic implications.N Engl J Med,1971;285(21)∶1182-1186.
  • 2Wang Y,Fei D,Vanderlaan M,et al.Biological activity of bevacizumab,ahumanized anti-VEGF antibody in vitro.Angiogenesis,2004;7(4)∶335-345.
  • 3Wilhelm SM,Carter C,Tang L,et al.BAY 43-9006 exhibits broad spec-trum oral antitumor activity and targets the RAF/MEK/ERK pathway and re-ceptor tyrosine kinases involved in tumor progression and angiogenesis.Canc-er Res,2004;64(19)∶7099-7109.
  • 4Dienstmann R,Markman B,Tabernero J.Application of Monoclonal Anti-bodies as Cancer Therapy in Solid Tumors.Curr Clin Pharmacol,2012;7(2)∶137-145.
  • 5吴秋玲,孔庆志.中药抗肿瘤血管生成的研究进展[J].世界中西医结合杂志,2010,5(1):87-89. 被引量:6
  • 6Tan W,Lu J,Huang M,et al.Anti-cancer natural products isolated fromChinese medicinal herbs.Chin Med,2011;6(1)∶27-31.
  • 7Jorgens K,Schaker K,Kroll J.The model organism zebrafish in biomed-ical research:applications and perspectives in vascular biology and medicine.Dtsch Med Wochenschr,2011;136(37)∶1865-1868.
  • 8Baker M.Screening:the age of fishes.Nat Methods,2011;8(1)∶47-51.
  • 9Cross LM,Cook MA,Lin S,et al.Rapid analysis of angiogenesis drugs ina live fluorescent zebrafish assay.Arterioscler Thromb Vasc Biol,2003;23(5)∶911-912.
  • 10Karamysheva AF.Mechanisms of angiogenesis.Biochemistry(Mosc),2008;73(7)∶751-62.

二级参考文献29

共引文献5

同被引文献128

引证文献6

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部